Cargando…

Overcoming rituximab drug-resistance by the genetically engineered anti-CD20-hIFN-α fusion protein: Direct cytotoxicity and synergy with chemotherapy

Treatment of patients with B-NHL with rituximab and CHOP has resulted in significant clinical responses. However, a subset of patients develops resistance to further treatments. The mechanism of unresponsiveness in vivo is not known. We have reported the development of rituximab-resistant clones der...

Descripción completa

Detalles Bibliográficos
Autores principales:	VEGA, GABRIEL G., FRANCO-CEA, LUZ ARELI, HUERTA-YEPEZ, SARA, MAYANI, HÉCTOR, MORRISON, SHERIE L., BONAVIDA, BENJAMIN, VEGA, MARIO I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735703/ https://www.ncbi.nlm.nih.gov/pubmed/26398317 http://dx.doi.org/10.3892/ijo.2015.3170

Ejemplares similares

Recombinant virus expressing hIFN-λ1 (rL-hIFN-λ1) has important effects on endoplasmic reticulum stress, autophagy and apoptosis in small cell lung cancer
por: Yan, Yulan, et al.
Publicado: (2020)

AAV2-Mediated Subretinal Gene Transfer of hIFN-α Attenuates Experimental Autoimmune Uveoretinitis in Mice
por: Tian, Lichun, et al.
Publicado: (2011)

Heparan Sulfate Facilitates Binding of hIFNγ to Its Cell-Surface Receptor hIFNGR1
por: Miladinova, Elisaveta, et al.
Publicado: (2022)

P38 MAPK expression and activation predicts failure of response to CHOP in patients with Diffuse Large B-Cell Lymphoma
por: Vega, Gabriel G., et al.
Publicado: (2015)

Recombinant Newcastle disease virus expressing human IFN‐λ1 (rL‐hIFN‐λ1)‐induced apoptosis of A549 cells is connected to endoplasmic reticulum stress pathways
por: Yan, Yulan, et al.
Publicado: (2018)

Antibody-CD20-interferon-alpha fusion protein has superior in vivo activity against human B cell lymphomas compared to Rituximab, and enhanced complement-dependent cytotoxicity in vitro
por: Yamada, Reiko, et al.
Publicado: (2013)

Recombinant Newcastle disease virus expressing human IFN-λ1 (rL-hIFN-λ1) inhibits lung cancer migration through repolarizating macrophage from M2 to M1 phenotype
por: Yan, Yulan, et al.
Publicado: (2020)

A phase II study of recombinant interferon-beta (r-hIFN-beta 1a) in combination with 5-fluorouracil (5-FU) in the treatment of patients with advanced colorectal carcinoma.
por: Joffe, J. K., et al.
Publicado: (1997)

Overcoming bortezomib resistance in human B cells by anti-CD20/rituximab-mediated complement-dependent cytotoxicity and epoxyketone-based irreversible proteasome inhibitors
por: Verbrugge, Sue Ellen, et al.
Publicado: (2013)

Downregulation of A20 increases the cytotoxicity of IFN-γ in hepatocellular carcinoma cells
por: Yin, Lei, et al.
Publicado: (2017)

Ibrutinib inhibits antibody dependent cellular cytotoxicity induced by rituximab or obinutuzumab in MCL cell lines, not overcome by addition of lenalidomide
por: Albertsson-Lindblad, Alexandra, et al.
Publicado: (2019)

Association of rituximab with graphene oxide confers direct cytotoxicity for CD20-positive lymphoma cells
por: Luo, Chengke, et al.
Publicado: (2016)

Gemcitabine enhances rituximab‐mediated complement‐dependent cytotoxicity to B cell lymphoma by CD20 upregulation
por: Hayashi, Kazumi, et al.
Publicado: (2016)

SynergyFinder 2.0: visual analytics of multi-drug combination synergies
por: Ianevski, Aleksandr, et al.
Publicado: (2020)

Correlation of the expression of YY1 and Fas cell surface death receptor with apoptosis of peripheral blood mononuclear cells, and the development of multiple organ dysfunction in children with sepsis
por: Reséndiz-Martínez, Judith, et al.
Publicado: (2017)

Correction to ‘SynergyFinder 2.0: visual analytics of multi-drug combination synergies’
Publicado: (2022)

Expression of phosphorylated raf kinase inhibitor protein (pRKIP) is a predictor of lung cancer survival
por: Huerta-Yepez, Sara, et al.
Publicado: (2011)

Remotely: Synergy with LSS probes (20'+10')
por: Kitching, Thomas
Publicado: (2016)

Death receptor 5 expression is inversely correlated with prostate cancer progression
por: HERNANDEZ-CUETO, ANGELES, et al.
Publicado: (2014)

Death receptor 5 expression is inversely correlated with prostate cancer progression
por: Hernandez-Cueto, Angeles, et al.
Publicado: (2017)

Tofacitinib overcomes an IFNγ‐induced decrease in NK cell‐mediated cytotoxicity via the regulation of immune‐related molecules in LC‐2/ad
por: Okita, Riki, et al.
Publicado: (2021)

HIF-1 expression is associated with CCL2 chemokine expression in airway inflammatory cells: implications in allergic airway inflammation
por: Baay-Guzman, Guillermina J, et al.
Publicado: (2012)

Targeting IFN/STAT1 Pathway as a Promising Strategy to Overcome Radioresistance
por: Liu, Shuya, et al.
Publicado: (2020)

The cytotoxic synergy of nanosecond electric pulses and low temperature leads to apoptosis
por: Muratori, Claudia, et al.
Publicado: (2016)

Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity
por: Coccia, Margherita, et al.
Publicado: (2017)

Immunotherapy of lidocaine allergy by intravenous desensitization using IFN‐gamma from a case: Overcoming impediments using IFN‐gamma during desensitization
por: Noh, Geunwoong, et al.
Publicado: (2019)

EMG-driven musculoskeletal model calibration with estimation of unmeasured muscle excitations via synergy extrapolation
por: Ao, Di, et al.
Publicado: (2022)

Synthesis and Anticancer Cytotoxicity of Azaaurones Overcoming Multidrug Resistance
por: Tóth, Szilárd, et al.
Publicado: (2020)

The regulation of hematopoietic stem cell populations
por: Mayani, Hector
Publicado: (2016)

Evaluation of synergy during co-pyrolysis of torrefied sawdust, coal and paraffin. A kinetic and thermodynamic dataset
por: Florentino-Madiedo, L., et al.
Publicado: (2021)

IFNγ synergies with cold atmospheric plasma in triggering colorectal cancer cell ferroptosis via the IFNγ/IFNR2/APC/TCF4/GPX4 axis
por: Lv, Xinyu, et al.
Publicado: (2023)

Cytotoxic and Antiproliferative Effect of Tepary Bean Lectins on C33-A, MCF-7, SKNSH, and SW480 Cell Lines
por: Valadez-Vega, Carmen, et al.
Publicado: (2014)

Structural Characterization of the Full-Length Anti-CD20 Antibody Rituximab
por: Belviso, Benny Danilo, et al.
Publicado: (2022)

MicroRNA-7 Regulates Migration and Chemoresistance in Non-Hodgkin Lymphoma Cells Through Regulation of KLF4 and YY1
por: Morales-Martinez, Mario, et al.
Publicado: (2020)

T-Cell Immunotherapy for Pediatric High-Grade Gliomas: New Insights to Overcoming Therapeutic Challenges
por: Haydar, Dalia, et al.
Publicado: (2021)

Primary diffuse large B-cell lymphoma of the bone: bendamustine and rituximab are able to overcome resistant disease
por: Mondello, Patrizia, et al.
Publicado: (2014)

Identifying and overcoming rituximab resistance in diffuse large B-cell lymphoma using next-generation sequencing
por: Jeon, Youngwoo
Publicado: (2023)

Identification and overcoming rituximab resistance in diffuse large B-cell lymphoma using next-generation sequencing
por: Jeon, Min Ji, et al.
Publicado: (2023)

IFN-γ fails to overcome inhibition of selected macrophage activation events in response to pathogenic mycobacteria
por: Thirunavukkarasu, Shyamala, et al.
Publicado: (2017)

IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting
por: Takeda, Kazuyoshi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mnr1ohe3lnsebcais53to9m53l